Correlation between the immune response elicited in rabbits by env-recombinant avipox vaccines and the inhibition of HIV-1-specific functions

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 3, 2000, Pages 211-218

  Radaelli, Antonia ^a   Gimelli, Margherita ^a   Zanotto, Carlo ^a   De Giuli Morghen, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Animal model; Avipox virus; Epitope mapping; Live recombinant vaccine

Indexed keywords

LIVE VACCINE; RECOMBINANT VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FOWLPOX VIRUS; GENE CONSTRUCT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RESISTANCE; MEMORY CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

AIDS VACCINES; ANIMALS; AVIPOXVIRUS; CELL LINE; EPITOPE MAPPING; FOWLPOX VIRUS; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; RABBITS; VACCINES, SYNTHETIC;

EID: 0033953599     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00186-8     Document Type: Article

References (27)

1. Coffin J.M. Genetic variation in AIDS viruses. Cell. 46:1986;1-14.
2. Radaelli A., Kraus G., Schmidt A., Badel P., McClure J., Hu S.L., Morton W., De Giuli Morghen C., Wong-Staal F., Looney D. Genetic variation in a human immunodeficiency virus type 2 live-virus M. nemestrina vaccine model. J. Virol. 72:1998;7871-7884.
3. Heeney J.L. Primate models for AIDS vaccine development. AIDS. 10:1996;S115-S122.
4. Filice G., Cereda P.M., Varnier O.E. Infection of rabbits with human immunodeficiency virus. Nature. 335:1988;366-369.
5. Reina S., Markham P., Gard E. Serological, biological, and molecular characterization of New Zealand White rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus. J. Virol. 67:1993;5367-5374.
6. Speck R.F., Penn M.L., Wimmer J., Esser U., Hague B.F., Kindt T.J., Atchison R.E., Goldsmith M.A. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. J. Virol. 72:1998;5728-5734.
7. Girard M., Meignier B., Barré-Sinoussi F., Kieny M.P., Matthews T., Muchmore E., Nara P.L., Wei Q., Rimsky L., Weinhold K., Fultz P.N. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J. Virol. 69:1995;6239-6248.
8. Dalgleish A.G., Beverly P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
9. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
10. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
11. Bruck C., Thiriart C., Fabry L., Francotte M., Pala P., Van Opstal O., Culp J., Rosenberg M., De Wilde M., Heidt P., Heeney J. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine. 12:1994;1141-1148.
12. Girard M., van der Ryst E., Barré-Sinoussi F., Nara P., Tartaglia J., Paoletti E., Blondeau C., Jennings M., Verrier F., Meignier B., Fultz P.N. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus. Virology. 232:1997;98-104.
13. Heeney J.L., van Gils M.E., van der Meide P., De Giuli Morghen C., Ghioni C., Gimelli M., Radaelli A., Davis D., Åkerblom L., Morein B. The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. J. Med. Primatol. 27:1998;50-58.
14. Wagner R., Teeuwsen V.J., Deml L., Notka F., Haaksma A.G., Jhagjhoorsingh S.S., Niphuis H., Wolf H., Heeney J.L. Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection. Virology. 245:1998;65-74.
15. Radaelli A., De Giuli Morghen C. Expression of HIV-1 envelope gene by recombinant avipox viruses. Vaccine. 12:1994;1101-1109.
16. Taylor J., Trimarchi C., Weinberg R., Languet B., Guillemin F., Desmettre P., Paoletti E. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine. 9:1991;190-193.
17. SF2 env gene. Vaccine. 12:1994;1110-1117.
18. Haigwood N.L., Shuster J.R., Moore G.K., Lee H., Skiles P.V., Higgins K.W., Barr P.J., George-Nascimento C., Steimer K.S. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses. 6:1990;855-869.
19. Heeney J.L., Teeuwsen V.J.P., van Gils M., Bogers W.M.J., De Giuli Morghen C., Radaelli A., Barnett S., Morein B., Åkerblom L., Wang Y., Lehner T., Davis D. β-Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc. Natl. Acad. Sci. USA. 95:1998;10803-10808.
20. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., McMichael A., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:1995;59-64.
21. Harrer T., Harrer E., Kalams S.A., Barbosa P., Trocha A., Johnson R.P., Elbeik T., Feinberg M.B., Buchbinder S.P., Walker B.D. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156:1996;2616-2623.
22. Heeney J.L., Bruck C., Goudsmit J., Montagnier L., Schultz A., Tyrrell D., Zolla-Pazner S. Immune correlates of protection from HIV infection and AIDS. Immunol. Today. 18:1997;4-8.
23. 287 challenge. Virology. 242:1998;150-160.
24. Ruegg C.L., Monell C.R., Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:1989;3257-3260.
25. Marcon L., Choe H., Martin K.A., Farzan M., Ponath P.D., Wu L., Newman W., Gerard N., Gerard C., Sodroski J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71:1997;2522-2527.
26. Kraus G., Radaelli A., Talbott R., Leavitt M., Schmidt A., Badel P., Bartz C., Morton W., Wong-Staal F., Looney D. Characterization of a molecular clone of HIV type 2 infectious for Macaca nemestrina. AIDS Res. Hum. Retroviruses. 14:1998;65-77.
27. Lee Y.-M., Tian C.-J., Yu X-F. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of gag precursors in a cell type-dependent manner. J. Virol. 72:1998;9061-9068.